Ride the Pharma Wave with Our Rights Issue!

Share via:


Mumbai (Maharashtra) [India], April 28: Remedium Lifecare Limited (BSE: 539561) has announced the launch of its much-anticipated Rights Issue, which has received approval from the Bombay Stock Exchange (BSE). This strategic initiative marks a significant step in the company’s journey toward becoming a vertically integrated, research-driven pharmaceutical leader. The Rights Issue will open on April 30, 2025, and close on May 14, 2025.

The capital raise comes on the heels of Remedium’s recent ₹182.7 crore agreement with a prominent UK-based…



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Popular

More Like this

Ride the Pharma Wave with Our Rights Issue!


Mumbai (Maharashtra) [India], April 28: Remedium Lifecare Limited (BSE: 539561) has announced the launch of its much-anticipated Rights Issue, which has received approval from the Bombay Stock Exchange (BSE). This strategic initiative marks a significant step in the company’s journey toward becoming a vertically integrated, research-driven pharmaceutical leader. The Rights Issue will open on April 30, 2025, and close on May 14, 2025.

The capital raise comes on the heels of Remedium’s recent ₹182.7 crore agreement with a prominent UK-based…



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Website Upgradation is going on for any glitch kindly connect at office@startupnews.fyi

More like this

Microsoft and OpenAI: From allies to rivals in the...

The once-thriving partnership between Microsoft and OpenAI is...

Pet care startup Petjio World in talks to raise...

Pet care startup Petjio World is in the...

AI startup AlonOS rolls out AI agent for business...

Artificial intelligence (AI) startup AIonOS — a joint...

Popular

Upcoming Events

Beijing to invest in blockchain, integrate into infrastructure

The Beijing city administration has announced a plan...

Animoca Brands opens its first Middle East office

Omar Elassar, formerly with Polkadot and Ripple, will...

Some Amazon sellers skip Prime Day due to Trump...

Typically held in July, Prime Day has been...
GdfFD GFD GFD GFD GFD GFD GFD